Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
In terms of overall survival rates, the tricaprin group had 100% three-year and five-year survival rates. In contrast, the control group had a 78.6% three-year survival rate and a 68.1% five-year survival rate.
Cardiology March 11th 2025
Oncology News Central (ONC)
The phase 3 ALLELE trial demonstrated tabelecleucel’s potential with a 50.7% overall response rate and median duration of response of 23.0 months in EBV+ PTLD patients.
Hematology/Oncology February 3rd 2025
MDLinx
Rapunzel syndrome represents a complex intersection of psychiatric and gastrointestinal pathology, often remaining asymptomatic for years before presenting with serious complications.
Emergency Medicine January 30th 2025
Cleveland Clinic Journal of Medicine (CCJM)
The belief that only painful masses are worrisome is incorrect – tumor growth rate and size remain the most crucial indicators for potential malignancy.
Oncology, Medical January 21st 2025
Epidermolysis Bullosa News
The constant presence of pain affects every aspect of daily living, with minimal friction causing severe blistering and requiring multiple daily wound care interventions across numerous body sites.
Dermatology January 9th 2025
Less than half of the 26,000 annual rhabdomyolysis cases in the United States are exercise-related, but early recognition remains crucial for preventing severe complications.
Emergency Medicine October 23rd 2024